Combined analysis of SATB1 and EMT markers expressions may have significant values in determining invasion and metastasis and assessing prognosis of ccRCC, and SATB1 might also have a potential value of being a good molecular target for ccRCC therapy. This evidence concerns the gene SATB1 and nonpapillary renal cell carcinoma.